How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

941 results for

Fibromyalgia Pharmacologic Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Pharmacological management of migraine

Pharmacological management of migraine SIGN 155 • Pharmacological management of migraine A national clinical guideline February 2018 Evidence www.healthcareimprovementscotland.org Edinburgh Office | Gyle Square |1 South Gyle Crescent | Edinburgh | EH12 9EB Telephone 0131 623 4300 Fax 0131 623 4299 Glasgow Office | Delta House | 50 West Nile Street | Glasgow | G1 2NP Telephone 0141 225 6999 Fax 0141 248 3776 The Healthcare Environment Inspectorate, the Scottish Health Council, the Scottish (...) management of migraine A national clinical guideline February 2018Scottish Intercollegiate Guidelines Network Gyle Square, 1 South Gyle Crescent Edinburgh EH12 9EB www.sign.ac.uk First published February 2018 ISBN 978 1 909103 62 7 Citation text Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of migraine. Edinburgh: SIGN; 2018. (SIGN publication no. 155). [February 2018]. Available from URL: http://www.sign.ac.uk SIGN consents to the photocopying of this guideline

2018 SIGN

2. Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology (PubMed)

Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology Fibromyalgia syndrome (FMS) is a chronic condition with unknown aetiology. The pathophysiology of the disease is incompletely understood; despite advances in our knowledge with regards to abnormal central and peripheral pain processing, and hypothalamo-pituitary-adrenal dysfunction, there is no clear specific pathophysiological therapeutic target. The management of this complex condition has thus perplexed (...) the medical community for many years, and several national and international guidelines have aimed to address this complexity. The most recent guidelines from European League Against Rheumatism (EULAR) (2016), Canadian Pain Society (2012), and The Association of the Scientific Medical Societies in Germany (AWMF) (2012) highlight the change in attitudes regarding the overall approach to FMS, but offer varying advice with regards to the use of pharmacological agents. Amitriptyline, Pregabalin and Duloxetine

Full Text available with Trip Pro

2017 Biomedicines

3. Fibromyalgia Pharmacologic Management

Fibromyalgia Pharmacologic Management Fibromyalgia Pharmacologic Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Fibromyalgia Pharmacologic Management Fibromyalgia Pharmacologic Management Aka: Fibromyalgia Pharmacologic Management From Related Chapters II. Precautions Non-medication is the mainstay of management See Medications have underwhelming benefit in approaches 10 III. Management: Antidepressants Benefits Assists with local pain, stiffness and sleep Does not affect s s More effective than and Milnacipran ( ) First week: 10 mg orally at bedtime Next three weeks: 25 mg orally at bedtime Later: 50 mg orally

2018 FP Notebook

4. Fibromyalgia Non-Pharmacologic Management

Fibromyalgia Non-Pharmacologic Management Fibromyalgia Non-Pharmacologic Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Fibromyalgia Non-Pharmacologic Management Fibromyalgia Non-Pharmacologic Management Aka: Fibromyalgia Non-Pharmacologic Management From Related Chapters II. Management: Reassurance and Education Common, non-life threatening, real condition Extensive lab testing is unlikely to be helpful Establishing relationship with one doctor is helpful Positive and empathic physician Review how the diagnosis was made with the patient Firm diagnosis is key to improvement Outline the therapeutic plan Emphasize

2018 FP Notebook

5. Fibromyalgia

: Fibromyalgia is a debilitating chronic disease characterized by musculoskeletal pain, fatigue, and compromises (...) in cognition. One of the biggest challenges surrounding fibromyalgia is proper diagnosis, as there is no current diagnostic test established. Most practitioners utilize examining tender points and other subjective self-assessments to aid in the assessment of the condition. Current therapies include both medication and non-pharmacologic such as chiropractic therapy, acupuncture, aerobic (...) exercise, and yoga. Yoga is an ancient Indian practice incorporating physical poses, deep breathing, self-awareness 2016 8. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia , Crohn's disease, and other chronic pain disorders. Chronic inflammatory diseases are complex to treat and have an impact on a large number of patients. Due to the difficulty of treating these diseases and the great impact on quality of life

2018 Trip Latest and Greatest

6. EULAR revised recommendations for the management of fibromyalgia (PubMed)

EULAR revised recommendations for the management of fibromyalgia The original European League Against Rheumatism recommendations for managing fibromyalgia assessed evidence up to 2005. The paucity of studies meant that most recommendations were 'expert opinion'.A multidisciplinary group from 12 countries assessed evidence with a focus on systematic reviews and meta-analyses concerned with pharmacological/non-pharmacological management for fibromyalgia. A review, in May 2015, identified eligible (...) four main stages are suggested underpinned by shared decision-making with patients. Initial management should involve patient education and focus on non-pharmacological therapies. In case of non-response, further therapies (all of which were evaluated as 'weak for' based on meta-analyses) should be tailored to the specific needs of the individual and may involve psychological therapies (for mood disorders and unhelpful coping strategies), pharmacotherapy (for severe pain or sleep disturbance

Full Text available with Trip Pro

2016 EvidenceUpdates

7. Pharmacological Management of Cancer Pain in Adults

Pharmacological Management of Cancer Pain in Adults Pharmacological Management of Cancer Pain in Adults National Clinical Guideline No. 9 November 2015Guideline Development Group The Pharmacological Management of Cancer Pain in Adults Guideline was developed by a subgroup of the Health Service Executive (HSE)/Royal College of Physicians (RCPI) National Clinical Programme for Palliative Care. The Core Guideline Development Group was supported by a group of senior multidisciplinary service leads (...) should be made by the practitioner taking into account the individual circumstances presented by each patient/ resident and available resources. Therapeutic options should be discussed with the responsible physician on a case-by-case basis as necessary.Table of Contents Section 1: Background 9 1.1. Grading of recommendations 9 1.1.1 Key to grading method used to highlight quality of evidence and recommendations: 9 1.2. Need for the National Clinical Guideline: pharmacological management of cancer

2015 Publication 4890888

8. Management of fibromyalgia: practical guides from recent evidence-based guidelines. (PubMed)

Management of fibromyalgia: practical guides from recent evidence-based guidelines. Fibromyalgia (FM) is a prevalent and costly condition worldwide, affecting approximately 2% of the general population. Recent evidence- and consensus‑based guidelines from Canada, Germany, Israel, and the European League Against Rheumatism aim to support physicians in achieving a comprehensive diagnostic workup of patients with chronic widespread (generalized) pain (CWP) and to assist patients and physicians (...) in applying healthy lifestyle practices. Aerobic and strengthening exercises should be the foundation of nonpharmacologic management. Cognitive behavioral therapies should be considered for those with mood disorder or inadequate coping strategies. Pharmacologic therapies may be considered for those with severe pain (duloxetine, pregabalin, tramadol) or sleep disturbance (amitriptyline, cyclobenzaprine, pregabalin). Multimodal programs should be considered for those with severe disability.

Full Text available with Trip Pro

2017 Polskie Archiwum Medycyny Wewnetrznej

9. EULAR revised recommendations for the management of fibromyalgia. (PubMed)

EULAR revised recommendations for the management of fibromyalgia. The original European League Against Rheumatism recommendations for managing fibromyalgia assessed evidence up to 2005. The paucity of studies meant that most recommendations were 'expert opinion'.A multidisciplinary group from 12 countries assessed evidence with a focus on systematic reviews and meta-analyses concerned with pharmacological/non-pharmacological management for fibromyalgia. A review, in May 2015, identified (...) , the following four main stages are suggested underpinned by shared decision-making with patients. Initial management should involve patient education and focus on non-pharmacological therapies. In case of non-response, further therapies (all of which were evaluated as 'weak for' based on meta-analyses) should be tailored to the specific needs of the individual and may involve psychological therapies (for mood disorders and unhelpful coping strategies), pharmacotherapy (for severe pain or sleep disturbance

Full Text available with Trip Pro

2017 Annals of the Rheumatic Diseases

10. A Systematic Review of Atypical Antipsychotics in Chronic Pain Management: Olanzapine Demonstrates Potential in Central Sensitization, Fibromyalgia, and Headache/Migraine. (PubMed)

A Systematic Review of Atypical Antipsychotics in Chronic Pain Management: Olanzapine Demonstrates Potential in Central Sensitization, Fibromyalgia, and Headache/Migraine. Many psychopharmacologic agents are used as primary or adjuncts in pain management. Atypical antipsychotics (AAs) have also been used as adjuncts in pain management regimens in a variety of manners; however, their efficacy in this capacity is unclear.A systematic review of all studies examining AA use for pain was conducted (...) , risperidone, aripiprazole, and ziprasidone are the only AAs with published studies in pain management. Among these, olanzapine and quetiapine have the most studies (11 and 6, respectively). Olanzapine shows preliminary and consistent efficacy in fibromyalgia and headache/migraine, although only 1 study was a randomized controlled trial with level I evidence of efficacy. Other AAs eg, (quetiapine) fail to demonstrate efficacy in pain syndromes and/or lack robust study designs.Few studies have been

2017 The Clinical Journal of Pain

11. Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia

Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) 1 year follow-up. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 420 participants Allocation: Randomized Intervention Model: Parallel Assignment Intervention Model Description: Non-pharmacologic trial comparing behavioral and exercise-based treatments Masking: Double (Investigator, Outcomes Assessor) Primary Purpose: Treatment Official Title: Multi-site Randomized Clinical Trial of FIT Teens for Juvenile Fibromyalgia

2017 Clinical Trials

12. Management of Widespread Pain and Fibromyalgia (PubMed)

Management of Widespread Pain and Fibromyalgia Specialists' views of fibromyalgia (FM) are typically colored by their experiences of the selected, complex cases that they are regularly called to evaluate. At a population level, it is crucial to recognize that education which promotes patient empowerment and non-pharmacological interventions which support self-management are very effective. The temptation, for both physician and patient, to first reach for pharmacological interventions should (...) are considered priorities at the level of the individual patient. In those patients who do require pharmacological support, patients should not be led to expect significant gains in isolation. The importance of self-management requires emphasis at each and every tier of management. It is true that advances in our understanding of neurobiology have greatly informed the selection of adjunctive drug classes which may provide benefit (as well as those which do not-as is the case of opioids). However, further

Full Text available with Trip Pro

2016 Current Treatment Options in Rheumatology

13. Management of fibromyalgia syndrome in 2016 (PubMed)

Management of fibromyalgia syndrome in 2016 Fibromyalgia syndrome is a chronic pain disorder and defies definitively efficacious therapy. In this review, we summarize the results from the early treatment research as well as recent research evaluating the pharmacological, interventional and nonpharmacological therapies. We further discuss future directions of fibromyalgia syndrome management; we specifically focus on the issues that are associated with currently available treatments

Full Text available with Trip Pro

2016 Pain management

14. More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: A meta-analysis examining six core symptoms. (PubMed)

More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: A meta-analysis examining six core symptoms. This study aimed to characterize and compare the efficacy profile on six fibromyalgia syndrome (FM) core symptoms associated with pharmacologic and non-pharmacologic treatments. We screened PubMed, Embase and the Cochrane Library for FM articles from 1990 to September 2012 to analyse randomized controlled trials comparing pharmacologic or non (...) for the management of multiple core FM symptom domains. Only amitriptyline demonstrated a significant effect on as many as three core FM symptoms, but it exhibited many adverse effects and was subject to early tachyphylaxis. Studies involving non-pharmacologic approaches (n = 64) were typically of poorer quality but were more often dedicated to multidimensional targets. Pool therapy demonstrated significant effects on five symptom domains, repetitive transcranial magnetic stimulation on four domains

Full Text available with Trip Pro

2014 European Journal of Pain

15. Yoga as an Effective Therapy to Reduce Symptoms in Patients with Fibromyalgia

, and compromises in cognition. One of the biggest challenges surrounding fibromyalgia is proper diagnosis, as there is no current diagnostic test established. Most practitioners utilize examining tender points and other subjective self-assessments to aid in the assessment of the condition. Current therapies include both medication and non-pharmacologic such as chiropractic therapy, acupuncture, aerobic exercise, and yoga. Yoga is an ancient Indian practice incorporating physical poses, deep breathing, self (...) -awareness, and meditation. Yoga is an effective therapy modality for managing chronic illnesses including low back pain and arthritis. Although there is no cure for fibromyalgia, several studies considered yoga as a therapy for symptom management. Can yoga be an effective therapy for symptom reduction in patients with chronic fibromyalgia? Methods: An exhaustive search of available medical literature using MEDLINE- Ovid, Web of Science and CINAHL was performed using the following key terms

2016 Pacific University EBM Capstone Project

16. Does exercise improve symptoms in fibromyalgia?

Does exercise improve symptoms in fibromyalgia? It has been proposed that fibromyalgia could be managed by pharmacological and non-pharmacological interventions. Regular physical exercise is commonly used as a non-pharmacological intervention. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified 14 systematic reviews including 25 randomized trials. We combined the evidence using meta-analysis and generated a summary of findings table following (...) the GRADE approach. We conclude that regular physical exercise probably reduces pain in patients with fibromyalgia.

Full Text available with Trip Pro

2016 Medwave

17. Treatments for Fibromyalgia in Adult Subgroups

treatments may behave differently in subgroups, evidence to date is largely insufficient for fibromyalgia subgroup effects of interventions other than duloxetine in adults with concomitant MDD. Future studies should be designed to support subgroup analysis to improve clinical applicability. vi Contents Executive Summary ES-1 Introduction 1 Background 1 Diagnosis 1 Treatment Strategies 1 Pharmacologic Treatments 2 Nonpharmacologic Treatments for Fibromyalgia 2 Rationale for Review 3 Selection of Patient (...) . Treatment Effectiveness in Fibromyalgia Subgroups 15 Overview 15 Key Points 15 Pharmacologic Therapies 15 Subgroup Outcomes 16 Physical Treatments 19 Psychological Therapies 20 Mixed Types of Treatments 21 Key Question 2. Adverse Treatment Effects in Fibromyalgia Subgroups 21 Key Points 22 RCTs 22 Pure Subgroup RCTs 22 Pooled IPD RCT Analyses 22 Observational Studies 22 Discussion 37 Key Findings and Strength of Evidence 37 Applicability and Limitations of the Evidence Base 38 Limitations

2015 Effective Health Care Program (AHRQ)

18. Fibromyalgia

is to discuss when fibromyalgia should be considered as a diagnosis, how it is diagnosed, the current understanding of the pathophysiology of fibromyalgia and the management strategies available. Discussion The features of fibromyalgia are similar to those of many other chronic illnesses, sometimes resulting in diagnostic confusion. Fibromyalgia can co-exist with other disorders and it is important to consider the possibility of fibromyalgia contributing to symptoms in any chronically ill patient. Keywords (...) ), these patients can still develop the changes of central sensitisation. Therefore, if patients have clinical features out of keeping with general disease activity, then it may be necessary to consider whether central sensitisation could be contributing. Management of fibromyalgia Team management Fibromyalgia is a complex disorder, requiring input from many different health care providers, including medical, allied health, and complementary and alternative medicine practitioners. General practitioners

2014 Clinical Practice Guidelines Portal

19. Fibromyalgia Pharmacologic Management

Fibromyalgia Pharmacologic Management Fibromyalgia Pharmacologic Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Fibromyalgia Pharmacologic Management Fibromyalgia Pharmacologic Management Aka: Fibromyalgia Pharmacologic Management From Related Chapters II. Precautions Non-medication is the mainstay of management See Medications have underwhelming benefit in approaches 10 III. Management: Antidepressants Benefits Assists with local pain, stiffness and sleep Does not affect s s More effective than and Milnacipran ( ) First week: 10 mg orally at bedtime Next three weeks: 25 mg orally at bedtime Later: 50 mg orally

2015 FP Notebook

20. Fibromyalgia Non-Pharmacologic Management

Fibromyalgia Non-Pharmacologic Management Fibromyalgia Non-Pharmacologic Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Fibromyalgia Non-Pharmacologic Management Fibromyalgia Non-Pharmacologic Management Aka: Fibromyalgia Non-Pharmacologic Management From Related Chapters II. Management: Reassurance and Education Common, non-life threatening, real condition Extensive lab testing is unlikely to be helpful Establishing relationship with one doctor is helpful Positive and empathic physician Review how the diagnosis was made with the patient Firm diagnosis is key to improvement Outline the therapeutic plan Emphasize

2015 FP Notebook

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>